Elevance Health, Inc. (ELV)
Elevance Health, Inc. (ELV) from its SEC filings: 2025 revenue $199.1 billion (+12% vs the year before), net margin 3%, free cash flow $3.2 billion. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Hospital & Medical Service Plans |
| Revenue (2025) | $199.1 billion |
| Revenue growth | +12% |
| Net income | $5.7 billion |
| Net margin | 2.8% |
| Free cash flow | $3.2 billion |
| Diluted EPS | $25.21 |
| Latest quarter (Q3 2026 (calendar)) revenue vs a year earlier | +1% |
| Cash | $10.3 billion |
| Long-term debt | $30.4 billion |
| Share count, 1 year | -3% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.